In fact, ARID1A deficiency has been shown to lead to the inactivation of MMR genes, increase in PD-L1 expression, increase in tumor mutation burden through DDR dysfunction via ATR inhibition, and TIL recruitment and inflammatory response by IL-6 production (Hu et al., 2020; Wang et al., 2020). This evidence concerns the gene CD274 and neoplasm.